We next sought to address the correlation between CNA frequencies and expression levels of MYC, EGFR, ASAP1, IRF2BP2, CCT5, and DRD1 in broad BC cell lines and breast tumors and the clinical relevance of the genes to patients with BC. This evidence concerns the gene CCT5 and breast cancer.